ORLANDO, Fla., Aug. 9, 2016 /PRNewswire/ -- Valensa International today announced the addition of Flex Pro ES™ Chewables
Photo - http://photos.prnewswire.com/prnh/20160809/396700
According to Dr. Rudi E. Moerck, President and CEO of Valensa, the chewable form of Flex Pro ES™ allows a broader and growing group of people to take advantage of one of the most successful joint health formulas introduced to the market in the last five years. "About 40 percent of Americans have issues swallowing pills, while some people have diets where fluid intake is limited. For some people, swallowing issues are severe enough to prevent them from using pills altogether. Industry standard glucosamine chondroitin-based products have not been successfully delivered as chewables to date and many other leading joint health ingredients have taste issues," he said. "Flex Pro ES™ Chewables offer a unique delivery system in the form of a great tasting, sugar-free chewable tablet. The product is a perfect solution for those who have difficulty swallowing. They are ideal for diabetics, seniors and people on-the-go," he added. Dr. Moerck went on to say that, in addition to targeting older consumers with joint health issues, Flex Pro ES™ Chewables have additional applications in the Sports Nutrition market.
Valensa Now Sourcing Pure California Astaxanthin Raw Material
Valensa, a leading manufacturer of Natural Astaxanthin extract, offers very high quality extraction with a unique, proprietary, two-part process using all-natural Deep Extract® (high pressure) supercritical CO2 (ethanol and solvent free). Valensa's O2B® Peroxidation Blocker stabilization technology ensures long-term stability of 4 years and efficacy for the consumer. Most of Valensa's Astaxanthin raw material has been sourced from the company's facility located in coastal Chile. In response to market demand, the company has added a new source of raw materials from a California facility that develops the material exclusively for Valensa under its strict quality control standards. All of Valensa's Astaxanthin is extracted at the company's Florida facility.
According to Moerck, all Astaxanthin products are not the same when it comes to purity and stability. "Buyers of Astaxanthin should be concerned about some new sources of the ingredient that are coming onto the market. When Valensa formulates with this powerful antioxidant, we only use algae from several verified clean sources, including our own, and an extraction that meets rigorous international standards. There are several, good clean sources of the ingredient on the market today – from companies using a supercritical CO2 extraction process. Claims of purity should be examined closely – with independent analyses if necessary. Consumer trust in our industry is too important to leave to empty promises or a lower price," he said.
For further information, contact:Dr. Rudi Moerck, President & CEOVoice: 210-632-0695Fax: 352-483-2095www.valensa.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-joint-health-chewable-supplement-from-valensa-300311025.html
SOURCE Valensa International
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All